Susanna Naggie, MD

Associate Professor of Medicine
Member in the Duke Clinical Research Institute
Campus mail Dcri-2400 Pratt Street, Room 0311-BOX 3850, Durham, NC 27710
Phone (919) 684-2584
Email address susanna.naggie@duke.edu

Education and Training

  • Fellow in Infectious Diseases, Medicine, Duke University, 2007 - 2009
  • Chief Medical Resident - VAMC, Medicine, Duke University, 2006 - 2007
  • Medical Resident, Medicine, Duke University, 2002 - 2005
  • M.D., Johns Hopkins University, 2002

Publications

Burton, MJ, and Naggie, S. "Real-World Effectiveness of DAA Therapies in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection: 996 Veterans Can't Be Wrong." Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 64, no. 12 (June 2017): 1721-1723.

PMID
28199517
Full Text

Naggie, S, Marks, KM, Hughes, M, Fierer, DS, Macbrayne, C, Kim, A, Hollabaugh, K, Roa, J, Symonds, B, Brainard, DM, McHutchison, JG, Peters, MG, Kiser, JJ, Chung, R, and Team, ACTGAS. "Sofosbuvir Plus Ribavirin Without Interferon for Treatment of Acute Hepatitis C Virus Infection in HIV-1-Infected Individuals: SWIFT-C." CLINICAL INFECTIOUS DISEASES 64, no. 8 (April 15, 2017): 1035-1042.

Full Text

Naggie, S, Marks, KM, Hughes, M, Fierer, DS, Macbrayne, C, Kim, A, Hollabaugh, K, Roa, J, Symonds, B, Brainard, DM, McHutchison, JG, Peters, MG, Kiser, JJ, Chung, R, and AIDS Clinical Trials Group (ACTG) A5327 Study Team, . "Sofosbuvir Plus Ribavirin Without Interferon for Treatment of Acute Hepatitis C Virus Infection in HIV-1-Infected Individuals: SWIFT-C." April 2017.

PMID
28329053
Full Text

Chan, A, Patel, K, and Naggie, S. "Genotype 3 Infection: The Last Stand of Hepatitis C Virus." Drugs 77, no. 2 (February 2017): 131-144. (Review)

PMID
28074358
Full Text

Ho, SB, Monto, A, Peyton, A, Kaplan, DE, Byrne, S, Moon, S, Copans, A, Rossaro, L, Roy, A, Le, H, Dvory-Sobol, H, Zhu, Y, Brainard, DM, Guyer, W, Shaikh, O, Fuchs, M, Morgan, TR, and VALOR study team, . "Efficacy of Sofosbuvir Plus Ribavirin in Veterans With Hepatitis C Virus Genotype 2 Infection, Compensated Cirrhosis, and Multiple Comorbidities." Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association 15, no. 2 (February 2017): 282-288.

PMID
27237429
Full Text

Naggie, S. "Hepatitis C Virus, Inflammation, and Cellular Aging: Turning Back Time." Topics in Antiviral Medicine 25, no. 1 (February 2017): 3-6. (Review)

PMID
28402927
Scholars@Duke

Naggie, S, and Muir, AJ. "Oral Combination Therapies for Hepatitis C Virus Infection: Successes, Challenges, and Unmet Needs." Annual Review of Medicine 68 (January 2017): 345-358. (Review)

PMID
27686017
Full Text

Naggie, S, Holland, DP, Sulkowski, MS, and Thomas, DL. "Hepatitis C Virus Postexposure Prophylaxis in the Healthcare Worker: Why Direct-Acting Antivirals Don't Change a Thing." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 64, no. 1 (January 2017): 92-99. (Review)

PMID
27682067
Full Text

Alam, I, Brown, K, Donovan, C, Forlenza, J, Lauwers, K, Mah'moud, MA, Manch, R, Mohanty, SR, Prabhakar, A, Reindollar, R, DeMasi, R, Slim, J, Tandon, N, Villadiego, S, and Naggie, S. "Real-World Effectiveness of Simeprevir-containing Regimens Among Patients With Chronic Hepatitis C Virus: The SONET Study." Open Forum Infectious Diseases 4, no. 1 (January 2017): ofw258-null.

PMID
28480251
Full Text

Younossi, ZM, Stepanova, M, Sulkowski, M, Naggie, S, Henry, L, and Hunt, S. "Sofosbuvir and ledipasvir improve patient-reported outcomes in patients co-infected with hepatitis C and human immunodeficiency virus." November 2016.

PMID
27291391
Full Text

Pages